Cell Surface Markers Market, By Product Type (Flow Cytometers, Hematology Analyzers, Reagents and Kits), By Application (Disease Diagnosis and identification, Research/Drug Discovery), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jul 2023

Code : CMI3912

Pages :160

Formats :

Excel and PDF

Industry : Medical Devices

Cell Surface Markers MarketSize and Trends

Global cell surface markers market is estimated to be valued at US$ 31.9 billion in 2023 and is expected to exhibit a CAGR of 8.6% during the forecast period (2023-2030).

Figure 1. Global Cell Surface Markers Market Share (%), By Product Type, 2023

Global Cell Surface Markers Market– Drivers

Increasing use of cell markers in diagnostics

Increasing use of cell markers in diagnostics of chronic diseases like cancer is expected to drive the global cell surface markers market growth over the forecast period. For instance, according to an article published by the Journal Molecular and Cellular Pathology published on January 7, 2021, High-content screening has been helpful in understanding the various downstream effects of various treatments on cancer cells, particularly on organelle targets, measuring the overall cellular response effectively for novel candidate compounds, and assessing signaling heterogeneity. The rising use in understanding cancer cell response to novel drugs is expected to drive market growth.

Increasing launches of new technologies and products for cell marking

Increasing launch of new products to make the cell marking process more efficient is expected to drive the global cell surface markers market growth. For instance, on August 12, 2020, IDEXX Laboratories, Inc., a U.S.-based healthcare innovation company, announced the launch of the ProCyte One Hematology Analyzer. The new analyzer’s advanced technology delivers breakthrough workflow simplicity and consistent, accurate results at the point of care.

Figure 2. Global Cell Surface Markers Market Share (%), By Region, 2023

Global Cell Surface Markers Market- Regional Analysis

Among region, North America is estimated to hold a dominant position in the global cell surface markers market over the forecast period, owing to increasing launches of products. For instance, in March 2022, Beckman Coulter Inc., a U.S.-based global science and technology company, announced launch of CellMek SPS, a fully automated sample preparation system for clinical flow cytometry. It is a fully automated sample preparation system (SPS) offers on-demand processing for a multitude of sample types to help laboratories to expand capabilities.